Member Info for notrac

Many thanks banjomick, They're building a nice portfolio.

This would seem to the same size as ONZ-7 which is producing 10mmscf/d. Any comments?

Does anyone here know how much the software sells for, or the likely value of a licensing deal with South Korea?

They're currently quoting �33!

The RNS issued by FUM says that she was the UK Finance Director which is not the same as being the FD of Shield Diagnostics. Companies House records show her resigning as Secretary from the UK company in December. Her name is not mentioned in any of the Shield Diagnostic's RNS since flotation.

From what I can see, Angela, the new CFO, resigned as Secretary of Shield Therapeutics UK in early December. She had held that appointment for seven years. The FD of Shield was not Angela; she also left the company late last year after less than twelve months.

During his employment, the FD received 1.56m shares in options of which 500K have now expired (he exercised nearly all of them). Of the balance, the exercise prices are 56.5p, 61.5p, 71.5p, and 30p. Since options only vest if one is in employment, he may have had to walk away from these. You only walk away if do not think it is going to work, fear of another delay/placing, or if you asked to get on your bike. He also held 280,000 ordinary shares. There was also a sale by a PDMR in January when the price was a lot lower. Is there a morale issue down there?

The last RNS said that the preliminary results will be announced on March 14th. That is all. In the past when FUM have made important announcements, it has been a few days before the results. IMHO if we do not hear anything by March 14th, then it will just be the preliminary results. As for the FD, he will only have left of his own volition if he did not know of a TO or if he felt that the proposed deal is not generous enough, or is not life changing for him as opposed to the others. He may have attempted to threaten JB, was therefore let go, and the replacement was hired at very short notice. Alternative possibilities are salary issues, cost-cutting, institutional pressure, lack of follow-up on audit recommendations etc etc.

Finance Officer going with immediate effect! Hopefully the man was a safe pair of hands but not the right calibre for the the next stage. I imagine the incoming person will be given some options.

In view of the positive trading update, I can only assume that an institution is reducing its stake; the share price has fallen out of bed over the past two weeks.

Looks good. Current SP implies large discount.

Spread was tight this afternoon, which is good.

The numbers were in line with what I expected but I was obviously ahead of the market. GLA

Get the impression that 2400 is now support and 2500 is resistance. That may change tomorrow.

Thanks you brown-dog. IMO a takeout price will be higher than �28 per share. Anyway it's just rumours in my view.

Clearly been a leak.

Logic, which I know doesn't count for much, would say that this should be the better one because there are less shares in issue.

Looking at the chart since the beginning in early 2015, the SP has closed below the 200 day moving average on only one occasion: on December 6th 2017.

I am sure it will be positive, but how positive. IMO the market will be looking for sales around 90 to 100 million and profits before tax of 30 to 35 million for the half year. Anything above that will help the sp to the next level where 2400 becomes support rather than resistance.

SP did have a gone run up to Xmas. Possible explanation is MM's dropping price to get another Institution onboard at a better price.